By taking advantage of the differences in oxygen tension between the myocardium and tumors, PKM2 could inhibit the activity of the apoptotic protein p53 in myocardial tissues, thus preventing the apoptosis of myocardial cells while enhancing tumor regression in a lung cancer model [180]. Here, TP53 is linked to neoplasm.